Home›Articles›What the IGNYTE trial tested and what the label warns aboutArticleWhat the IGNYTE trial tested and what the label warns aboutArticlesConnectionsSourcesComments (0)Reader Challenges (0)ConnectionsArticle OnVusolimogene oderparepvec, Drugs and Medicinal Substances Well-attested SourcesVusolimogene oderparepvec (Wikipedia)History; Adverse effectsQuote, History; Adverse effectsan open-label, multiregional, single-arm trial in 140 adults with stage IIIB, IIIC or IV unresectable advanced melanomaView the SourceMedicine Atlas Original Articlestier 1Comments (0)No comments yet. Be the first to share a thought.Sign in to join the discussion.Reader Challenges (0)No disputes yet. Spotted an error or a better source? Open the first one.Sign in to dispute this or suggest a correction.